|
|
Valerio Therapeutics
PAR •
Healthcare •
Biotechnology •
Quote as of 07/03/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization249.22 mln
Float129 mln
Earnings Date07/28/2025
Key Fundamentals
EPS-0.02
RPS0.01
ROIC-2.39
ROA-27.41
EBITDA, mln0.54
EV / EBITDA193
EV / EBIT-24.07
Revenue, mln2.57
EV / Revenue40.75
Financial Strength
Altman Z-Score0.64
Piotroski F-Score
5
/ 9
Beneish M-Score-4.16
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
159% |
100
/ 100
 |
| 1 Month |
166% |
100
/ 100
|
| 2 Months |
343% |
100
/ 100
|
| 6 Months |
229% |
100
/ 100
|
| 1 Year |
697% |
100
/ 100
|
|
| |
